Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. - Wikidata - awgldk - TriplyDB

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.

http://www.wikidata.org/entity/Q35169306

about

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches Neoadjuvant chemotherapy in oral cancers: Selecting the right patients The role of systemic treatment before, during, and after definitive treatment MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma Synthetic and natural antioxidants attenuate cisplatin-induced vomiting In vivo optimisation study for multi-baseline MR-based thermometry in the context of hyperthermia using MR-guided high intensity focused ultrasound for head and neck applications.Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.Preclinical profile of cabazitaxel.A head and neck cancer tumor response-specific gene signature for cisplatin, 5-fluorouracil induction chemotherapy fails with added taxanes Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis.Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma.Lactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinoma Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.Sequential chemoradiation in locally advanced head and neck cancer after induction chemotherapy: an induction chemotherapy schedule more suited to a limited resource setting Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706).Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapy Systemic therapy strategies for head-neck carcinomas: Current status Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies.Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.Systemic therapy in head and neck cancer: changing paradigm.Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.Magnetic resonance-guided high-intensity focused ultrasound combined with radiotherapy for palliation of head and neck cancer-a pilot study Clinical features and treatment of squamous cell carcinoma of the breast.The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT.Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study Success of endoscopic pharyngoesophageal dilation after head and neck cancer treatment Radiation therapy is well tolerated and produces excellent control rates in elderly patients with locally advanced head and neck cancers.Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes.The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.

P2860

Q24200903-D3FD854A-155A-49A7-8E91-88870422E833 Q26767046-059BA852-4836-4962-8088-A17DB790BB14 Q26768434-1237909C-0380-4E02-AB56-5160FA32F32A Q26859285-CA8002D0-5709-4776-84CD-8E487C6473D5 Q28552305-9A35E3E1-3A95-454D-B2E4-0EBC3CC0C780 Q30834914-F326E2B8-562D-4610-9A37-3986F759071A Q30872312-1EF77DE4-624E-4F44-88B4-A001B1EF0B7A Q33425830-FD2737C1-84CF-482B-8514-C776589FC71D Q33433507-6F91753A-DB3F-4201-B1A5-8FCE08D75435 Q33725229-0AAEB54A-2BA8-452E-8024-A372DC793E22 Q33858049-8E86C45F-30BA-4804-BB1D-FE8B9958AFC5 Q34394251-74A6D062-5E90-43B8-BAAD-D840ACE0008F Q34442876-27E09A5C-4F5E-47B3-AC09-11B50CD77D92 Q34511068-2DEDA9E6-DC86-4AFC-82C1-FC1E5D5D6735 Q34779430-264812A8-4815-4C7F-B121-751962145901 Q35152720-B96E63BE-9793-464C-9DD4-FE408F687620 Q35469234-064D2830-6F0A-4B84-84AE-2D2801D9F012 Q35553791-2F54861F-6211-4FF8-A589-91788BEAC429 Q35606525-38DAC844-909F-4C31-9160-AC5086C6224F Q35694837-54A3809D-74C4-4D61-B5DF-17D6A5500286 Q35717521-F0AC4AAB-5CD5-48F7-9A4A-3473D2B1ACB8 Q35754239-FE730E07-5789-4E9B-836D-AB99E571DA71 Q36500014-94061B67-CFD5-47E2-BB4D-A673EDA29B03 Q36529843-9B1AB64D-D2DC-445E-B6AC-421E51669B21 Q36552692-992756CB-3D5A-4E52-9BBD-505DC2F6A1D6 Q36625201-D6217DEC-5E54-48D3-8AD1-FA93A4939D53 Q36627358-7C3E58F6-DF45-4C4B-846C-91E8DFB5EABB Q36685556-29CEFFDA-0C5C-43AF-A46C-C09CA10F6502 Q36697794-BCB37E35-B0F6-429B-8902-5DAD75BDD6E0 Q36714088-C5E0579D-10F9-49C0-AF17-D068D076381D Q36714584-3B8CB951-CD06-4009-ADC3-18C7F064F584 Q36759883-5386A6CD-32E6-412E-BDD0-285A587BFD06 Q36967896-08F91C23-ABB9-473E-99BB-B390AA9DA060 Q37190511-6BE10DEF-7F57-4344-8543-14A10A0A5A63 Q37301927-28BB9A1F-932D-4AEF-BA0F-A254EA32D0E1 Q37351321-F4CE51E7-7EB8-454E-A782-331F34B37614 Q37421934-8C07928C-C763-4502-BFDD-A37E208077B2 Q37594771-155E19A9-1665-457A-BA75-83EAF820E7C6 Q37658806-5CC892E6-8F16-4ADA-BE08-D5B1035D37E6 Q37925133-A9D4C6EE-C4AA-4A37-8B35-E329E30FEB1A

P2860

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.

http://www.wikidata.org/entity/Q35169306

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Induction chemotherapy with ci ...... 324 randomised phase 3 trial.

@ast

Induction chemotherapy with ci ...... 324 randomised phase 3 trial.

@en

type

label

Induction chemotherapy with ci ...... 324 randomised phase 3 trial.

@ast

Induction chemotherapy with ci ...... 324 randomised phase 3 trial.

@en

prefLabel

Induction chemotherapy with ci ...... 324 randomised phase 3 trial.

@ast

Induction chemotherapy with ci ...... 324 randomised phase 3 trial.

@en

P1433

Q35169306-B6D2A403-FC06-4E4F-931E-E56008880CB8

P1476

Q35169306-F47F5D05-8BF6-4FC4-B7A6-859D0EE95FDD

P2093

Q35169306-032D0848-E3C6-466B-A86F-64150227CF75

Q35169306-4C8BCE30-15E6-4633-BFE7-2CE41F1FDE55

Q35169306-515AC227-8C9E-4D90-8127-83B65BC4C10D

Q35169306-69137F84-4C9C-4A21-8FE5-98A53B49B50D

Q35169306-72B0DF35-9CDF-459D-AF72-E6D9FDEB4711

Q35169306-7D03C712-BFA5-436F-ACCB-BDF404D4E2BD

Q35169306-7F4C565B-E200-432A-8B5A-FBDD9179149D

Q35169306-B90EC802-7901-4124-A46B-48389F4B5BD0

Q35169306-D6D72092-C55F-4C38-8B28-1661CC106978

Q35169306-D7BFEBE5-71D5-41A0-8E24-71A5BEFD8058

P2860

Q35169306-04D95EA3-43E8-4E99-B967-B3262FC9086E

Q35169306-0B465529-3BD3-4B93-B922-EB960C8AACA8

Q35169306-0C0EB1B4-176B-4902-9A9D-CE379AA90294

Q35169306-0EF3539C-92F0-4FD3-9D15-6A0913E8BEF3

Q35169306-16180B83-55D6-4FE7-8A1D-13E8DC1E0B52

Q35169306-25CC8E0F-7526-4B3B-AEC8-CC1072727079

Q35169306-27C48797-CED5-459A-947A-F9BAB3EF5E6D

Q35169306-409438D2-DD44-4034-A0D4-96F9FF68BEB2

Q35169306-4884AE8B-B792-48DE-AE11-323D03C7B5D8

Q35169306-5C0E9404-ED7D-4750-BF90-C8956D378C8D

P304

Q35169306-CC89B3E0-48FF-4647-B52A-99D4A01102DA

P31

Q35169306-DD4B0854-03CF-43E2-BB78-166A5304380A

P356

Q35169306-3B3D7F1D-3258-4281-B62B-B83549CD9BB1

P433

Q35169306-702B5EF2-E56C-40F9-A3F5-EF66279D17B0

P478

Q35169306-29A7B904-6368-4EFB-AC4D-20CD6A144C72

P577

Q35169306-4CC241CD-6B20-4752-814A-5411C5765F14

P698

Q35169306-6FCDA25B-4492-47D3-99E2-37CC0C994925

P921

Q35169306-5A658CC3-F237-404E-8E32-8589F4681967

Q35169306-A893BB6F-DDB4-4D40-AAF9-20FDAC01C10C

P932

Q35169306-1676783D-0072-46EA-964E-5186CB0F55E3

P356

S1470-2045(10)70279-5

P1433

The Lancet Oncology

P1476

Induction chemotherapy with ci ...... 324 randomised phase 3 trial.

@en

P2093

Daniel E Sammartino

http://www.w3.org/2001/XMLSchema#string

Jochen H Lorch

http://www.w3.org/2001/XMLSchema#string

John Fasciano

http://www.w3.org/2001/XMLSchema#string

Kevin Cullen

http://www.w3.org/2001/XMLSchema#string

Marshall R Posner

http://www.w3.org/2001/XMLSchema#string

Ming Tan

http://www.w3.org/2001/XMLSchema#string

Nicholas Sarlis

http://www.w3.org/2001/XMLSchema#string

Olga Goloubeva

http://www.w3.org/2001/XMLSchema#string

Robert I Haddad

http://www.w3.org/2001/XMLSchema#string

Roy Tishler

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus and survival of patients with oropharyngeal cancer.

Global cancer statistics, 2002

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Second primary tumors in patients with head and neck squamous cell carcinoma.

P304

153-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(10)70279-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21233014

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

4356902

http://www.w3.org/2001/XMLSchema#string